As of Apr 29
| -0.45 / -1.02%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 47.17, with a high estimate of 59.76 and a low estimate of 35.00. The median estimate represents a +8.12% increase from the last price of 43.63.
The current consensus among 33 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since April, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.